The good, the bad and the ugly are all getting bundled together by the selling tide, the time to buy some more of VIV is getting near.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025